Christoph Michael Lanschuetzer

Summary

Affiliation: Paracelsus Private Medical University
Country: Austria

Publications

  1. pmc Transient anti-CD40L co-stimulation blockade prevents immune responses against human bullous pemphigoid antigen 2: implications for gene therapy
    Christoph M Lanschuetzer
    Department of Dermatology, Medical College of Wisconsin, Milwaukee, Wisconcin, USA
    J Invest Dermatol 129:1203-7. 2009
  2. doi request reprint Epidermolysis bullosa nevi
    Christoph Michael Lanschuetzer
    Department of Dermatology, Paracelsus Medical University, Mullner Hauptstr 48, Salzburg 5020, Austria
    Dermatol Clin 28:179-83. 2010

Collaborators

Detail Information

Publications2

  1. pmc Transient anti-CD40L co-stimulation blockade prevents immune responses against human bullous pemphigoid antigen 2: implications for gene therapy
    Christoph M Lanschuetzer
    Department of Dermatology, Medical College of Wisconsin, Milwaukee, Wisconcin, USA
    J Invest Dermatol 129:1203-7. 2009
    ....
  2. doi request reprint Epidermolysis bullosa nevi
    Christoph Michael Lanschuetzer
    Department of Dermatology, Paracelsus Medical University, Mullner Hauptstr 48, Salzburg 5020, Austria
    Dermatol Clin 28:179-83. 2010
    ..Given the skin fragility and potentially impaired wound healing in EB patients, we avoid prophylactic total excision of large EB nevi, but rather use the dermoscope to select appropriate sites for punch biopsies within giant EB nevi...